Holen Sie sich die Stockscreener-App
114.06
4.79%
5.48
Schlusskurs vom Vortag:
$108.58
Offen:
$110.44
24-Stunden-Volumen:
498.66K
Relative Volume:
0.39
Marktkapitalisierung:
$5.56B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-192.89M
KGV:
-29.26
EPS:
-3.8976
Netto-Cashflow:
$-172.97M
1W Leistung:
+8.76%
1M Leistung:
+28.89%
6M Leistung:
+4.22%
1J Leistung:
+752.92%
1-Tages-Spanne:
$108.93
$114.37
1-Wochen-Bereich:
$102.62
$114.37
52-Wochen-Spanne:
$13.31
$151.02
Celcuity Inc Stock (CELC) Company Profile
Firmenname
Celcuity Inc
Sektor
Branche
Telefon
763-392-0767
Adresse
16305 36TH AVENUE N, MINNEAPOLIS, MN
Compare CELC vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
114.06 | 5.26B | 0 | -192.89M | -172.97M | -3.8976 |
VRTX
Vertex Pharmaceuticals Inc
|
524.57 | 134.02B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.15 | 68.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
925.04 | 58.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.17 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.09 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-27 | Eingeleitet | Citizens | Mkt Outperform |
| 2025-12-12 | Eingeleitet | Wells Fargo | Overweight |
| 2025-11-18 | Eingeleitet | Wolfe Research | Outperform |
| 2025-11-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-09-22 | Eingeleitet | Guggenheim | Buy |
| 2025-07-01 | Fortgesetzt | Stifel | Buy |
| 2024-07-22 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-22 | Eingeleitet | Stifel | Buy |
| 2023-12-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-09-07 | Eingeleitet | Jefferies | Buy |
| 2021-07-29 | Eingeleitet | Cowen | Outperform |
| 2021-07-27 | Eingeleitet | Needham | Buy |
| 2021-01-28 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-11 | Fortgesetzt | Craig Hallum | Buy |
| 2018-11-20 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Celcuity Inc Aktie (CELC) Neueste Nachrichten
Precision Trading with Celcuity Inc. (CELC) Risk Zones - Stock Traders Daily
CELCCelcuity Inc Options - Finviz
Price to earnings forward of Celcuity Inc. – NASDAQ:CELC - TradingView
Price to sales forward of Celcuity Inc. – DUS:7VR - TradingView
Celcuity Inc.(NasdaqCM: CELC) dropped from Russell 2000 Value Benchmark - marketscreener.com
Celcuity Inc.(NasdaqCM: CELC) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
How Does Celcuity’s (CELC) Russell Index Exit Reframe Its Gedatolisib-Centered Investment Story? - simplywall.st
Celcuity Inc.(NasdaqCM: CELC) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Celcuity Inc.(NasdaqCM: CELC) dropped from Russell Microcap Index - marketscreener.com
Celcuity Inc.(NasdaqCM: CELC) dropped from Russell 3000E Index - marketscreener.com
Enterprise value to revenue forward of Celcuity Inc. – NASDAQ:CELC - TradingView
Celcuity Inc.(NasdaqCM: CELC) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Enterprise value to EBITDA forward of Celcuity Inc. – NASDAQ:CELC - TradingView
Enterprise value to EBITDA forward of Celcuity Inc. – MUN:7VR - TradingView
Enterprise value to revenue forward of Celcuity Inc. – MUN:7VR - TradingView
CELC Stock Records Worst Day Ever After Late-Stage Breast Cancer Trial Results — What’s Driving The Selloff? - Stocktwits
Enterprise value to EBIT forward of Celcuity Inc. – MUN:7VR - TradingView
Price to sales forward of Celcuity Inc. – MUN:7VR - TradingView
Celcuity Inc.(NasdaqCM: CELC) dropped from Russell 3000E Value Benchmark - marketscreener.com
Price to book forward of Celcuity Inc. – MUN:7VR - TradingView
Celcuity Inc. Actuals & Estimates (NASDAQ:CELC) - TradingView
CELC Stock Jumps After Hours On Positive Breast Cancer Trial Data - Stocktwits
CELC Forecast — Price Target — Prediction for 2027 - TradingView
A2JAAX Forecast — Price Target — Prediction for 2027 - TradingView
Why is Avoro Capital Advisors Making a Big Bet on Celcuity (CELC) - Kavout | AI
Celcuity Heads Toward A Major Regulatory Catalyst Next Month - RTTNews
Celcuity’s Breakout Run Now Hangs On An FDA Call - Finimize
Celcuity Inc (CELC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Celcuity Inc (CELC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Celcuity Inc (CELC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Celcuity Inc (CELC) Institutional Confidence - TradingKey
Celcuity Inc (CELC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Celcuity Inc (CELC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Celcuity Inc (CELC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Celcuity Inc (CELC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Celcuity Inc (CELC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Celcuity shares fall despite strong phase 3 breast cancer trial data (CELC) - MSN
Should Celcuity’s $500 Million Convertible Notes and VIKTORIA-1 Data Shift the CELC Investment Thesis Require Action From Celcuity (CELC) Investors? - simplywall.st
Trading the Move, Not the Narrative: (CELC) Edition - Stock Traders Daily
CELC News | CELCUITY INC (NASDAQ:CELC) - ChartMill
Guggenheim Initiates Coverage of Celcuity (CELC) with Buy Recommendation - MSN
CELC stock records worst day ever after late-stage breast cancer trial results — what’s driving the selloff? - MSN
ACT CAPITAL MANAGEMENT, LLC's Celcuity Inc(CELC) Holding History - GuruFocus
Celcuity raises $500M in upsized 0.25% convertible notes sale - MSN
TD Asset Management Inc Has $9.73 Million Stake in Celcuity, Inc. $CELC - MarketBeat
CELC6416934 Bond Coupon Analysis — Rate & Payments - TradingView
Director at Celcuity (CELC) receives 1,530-share stock grant and reports holdings - Stock Titan
Celcuity Refinances Debt with New Convertible Notes Offering - TipRanks
Celcuity Raises $575 Million in 0.25% Convertible Notes Due 2032; Net Proceeds $557 Million - TradingView
Geode Capital Management LLC Purchases 64,213 Shares of Celcuity, Inc. $CELC - MarketBeat
BNP Paribas Financial Markets Sells 36,648 Shares of Celcuity, Inc. $CELC - MarketBeat
Finanzdaten der Celcuity Inc-Aktie (CELC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Celcuity Inc-Aktie (CELC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Dalvey David | Director |
May 04 '26 |
Sale |
140.68 |
25,000 |
3,517,000 |
65,000 |
| Buller Richard E | Director |
May 04 '26 |
Option Exercise |
5.10 |
9,000 |
45,900 |
15,760 |
| Buller Richard E | Director |
May 04 '26 |
Sale |
140.46 |
9,000 |
1,264,181 |
6,760 |
1.16%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):